Skip to main content
Livermore
Livermore
ZHEN

Brooktree Capital Management

SEC CIK
0001021296
Latest filing
Aug 5, 2026

PFE holding history

Pfizer Inc in every 13F filed by Brooktree Capital Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q2 2026 holdings

Shares (Q2 2026)
101,128
Value
$2.44M
% of portfolio
1.6%
Quarters held
22
Since Q1 2021
Holdings of PFE by Brooktree Capital Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026101,128$2.44M1.6%−307−0.3%ReducedHolders
Q1 2026101,435$2.85M2.3%−19,075−15.8%ReducedHolders
Q4 2025120,510$3.00M2.0%−9,136−7.0%ReducedHolders
Q3 2025129,646$3.30M2.1%+8,291+6.8%AddedHolders
Q2 2025121,355$2.94M1.9%+3,184+2.7%AddedHolders
Q1 2025118,171$2.99M2.2%+2,788+2.4%AddedHolders
Q4 2024115,383$3.06M2.3%+1,389+1.2%AddedHolders
Q3 2024113,994$3.30M2.7%+1,316+1.2%AddedHolders
Q2 2024112,678$3.15M2.7%−8,574−7.1%ReducedHolders
Q1 2024121,252$3.36M2.6%+6,117+5.3%AddedHolders
Q4 2023115,135$3.31M2.7%−9,877−7.9%ReducedHolders
Q3 2023125,012$4.15M3.5%+3,640+3.0%AddedHolders
Q2 2023121,372$4.45M3.4%−4,228−3.4%ReducedHolders
Q1 2023125,600$5.12M4.0%−1,659−1.3%ReducedHolders
Q4 2022127,259$6.52M5.4%−2,557−2.0%ReducedHolders
Q3 2022129,816$5.68M4.7%+5,650+4.6%AddedHolders
Q2 2022124,166$6.51M4.9%+2,621+2.2%AddedHolders
Q1 2022121,545$6.29M4.1%+8,432+7.5%AddedHolders
Q4 2021113,113$6.68M4.1%−1,206−1.1%ReducedHolders
Q3 2021114,319$4.92M3.1%+2,302+2.1%AddedHolders
Q2 2021112,017$4.39M2.8%+17,348+18.3%AddedHolders
Q1 202194,669$3.43M2.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.